Cases & Deals

PharmaStem builds patent portfolio for umbilical cord blood stem cells and their therapeutic use

Clients PharmaStem Therapeutics, Inc.

Jones Day represented PharmaStem Therapeutics, Inc. and established its patent portfolio related to frozen umbilical cord blood hematopoietic stem cells and their therapeutic use.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.